HeartSciences (NASDAQ:HSCS) Price Target Lowered to $9.00 at Ascendiant Capital Markets

HeartSciences (NASDAQ:HSCS) had its target price lowered by Ascendiant Capital Markets from $15.00 to $9.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Separately, Wall Street Zen upgraded HeartSciences to a “sell” rating in a research report on Saturday, July 26th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $10.50.

HeartSciences Stock Up 2.6%

Shares of HSCS opened at $3.57 on Wednesday. The business’s 50 day moving average is $3.49 and its two-hundred day moving average is $3.52. The firm has a market cap of $9.46 million, a price-to-earnings ratio of -0.43 and a beta of 2.57. HeartSciences has a 52-week low of $2.52 and a 52-week high of $6.47.

HeartSciences (NASDAQ:HSCS) last posted its quarterly earnings data on Thursday, September 11th. The company reported ($1.58) EPS for the quarter, beating analysts’ consensus estimates of ($2.41) by $0.83. On average, equities analysts expect that HeartSciences will post -10.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in HeartSciences stock. Geode Capital Management LLC bought a new position in HeartSciences Inc. (NASDAQ:HSCS) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,599 shares of the company’s stock, valued at approximately $43,000. Geode Capital Management LLC owned 0.51% of HeartSciences at the end of the most recent reporting period. 17.24% of the stock is owned by hedge funds and other institutional investors.

About HeartSciences

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.